Angeborene Thrombozytenfunktionsstörungen

[1]  W. Korte,et al.  [Clinical assessment of potential fields of application of recombinant factor VIIa in internal and pediatric diseases. Recommendations of an expert group]. , 2007, Medizinische Klinik.

[2]  P. Nurden,et al.  Inherited disorders of platelets: an update , 2006, Current opinion in hematology.

[3]  M. Ozelo,et al.  Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard–Soulier syndrome , 2005, Annals of Hematology.

[4]  F. Adam,et al.  Bleeding risks associated with inheritance of the Quebec platelet disorder. , 2004, Blood.

[5]  P. Comfurius,et al.  Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids. , 2004, Biochimica et biophysica acta.

[6]  S. Bellucci,et al.  Molecular basis of Glanzmann's Thrombasthenia and current strategies in treatment. , 2002, Blood reviews.

[7]  V. Jiménez‐Yuste,et al.  Successful thyroidectomy in a patient with Hermansky–Pudlak syndrome treated with recombinant activated factor VII and platelet concentrates , 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[8]  P. Nurden,et al.  Role of ADP Receptor P2Y12 in Platelet Adhesion and Thrombus Formation in Flowing Blood , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[9]  K. Clemetson,et al.  Platelets in Thrombotic and Non-thrombotic Disorders: Platelet adhesive protein defect disorders , 2002 .

[10]  J. Mandel,et al.  Another link between phospholipid transmembrane migration and ABC transporter gene family, inferred from a rare inherited disorder of phosphatidylserine externalization. , 1997, Biochemical and biophysical research communications.

[11]  J. Calvete.  Clues for Understanding the Structure and Function of a Prototypic Human Integrin: The Platelet Glycoprotein IIb/IIIa Complex , 1994, Thrombosis and Haemostasis.

[12]  I. Schellenberg,et al.  Platelet membrane glycoprotein Ib: genetic polymorphism detected in the intact molecule and in proteolytic fragments. , 1990, Thrombosis research.

[13]  D. Fournier,et al.  Bernard-Soulier syndrome. , 1989, Bailliere's clinical haematology.

[14]  Caen,et al.  Gray platelet syndrome. Demonstration of alpha granule membranes that can fuse with the cell surface. , 1987, The Journal of clinical investigation.

[15]  J. Sixma,et al.  Patients with a prolonged bleeding time and normal aggregation tests may have storage pool deficiency: studies on one hundred six patients. , 1987, Blood.

[16]  J. Miller,et al.  Platelet-type von Willebrand's disease: characterization of a new bleeding disorder. , 1982, Blood.

[17]  A. Fauci,et al.  Decreased nucleotide and serotonin storage associated with defective function in Chediak-Higashi syndrome cattle and human platelets. , 1976, Blood.

[18]  G. Raccuglia.  Gray platelet syndrome. A variety of qualitative platelet disorder. , 1971, The American journal of medicine.

[19]  P. Pudlák,et al.  Albinism associated with hemorrhagic diathesis and unusual pigmented reticular cells in the bone marrow: report of two cases with histochemical studies. , 1959, Blood.